Quality by design with design of experiments approach for the development of a stability‐indicating LC method for benzonatate and its impurities in liquid oral dosage form

Abstract

A quality by design based simple and stability‐indicating liquid chromatography method has been developed successfully for benzonatate and its related impurities. The optimized high‐performance liquid chromatography method can be used to detect and quantify the benzonatate impurities in its finished liquid oral dosage forms. For the quantification of impurities demands more comprehensive way of analytical method development. Quality by design approach allows the assessment of various analytical parameters and their effects with minimum number of experiments. The current method has been separated five specified known impurities of benzonatate along with unspecified degradation products with adequate chromatographic resolution. The separation was acquired by using Zorbax SB CN, (4.6 × 250 mm), 5 μm column at a flow rate of 0.9 mL/min with a gradient elution mode. Mobile phase A consisting of 15 mM monobasic potassium phosphate (pH of 2.7) and tetrahydrofuran (90:10 v/v) and mobile phase B was mixture of acetonitrile and tetrahydrofuran (90:10 v/v). Detection of compounds was carried out at 310 nm and column temperature was maintained at 35°C. The drug product and drug substance were subjected to the stress conditions such as acid, base, oxidation, heat, and photolysis as per the recommendations of International Conference on Harmonization (Q2) methodology. The method was validated to be precise, specific, robust, rugged, and stability indicating.

Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach

“…The current DoE section, fraction factorial design was used for linear and interaction models. Compared to generic analytical method development, varying one factor at a time, application of DoE where all the factors are altered simultaneously to accelerate the risk assessment with greater influence [ 30 , 31 ]. By considering all these response factors (Table 3 ), the statistical experimental design chosen was fractional factorial design (FFD), with 15 experiments at two levels and three central points.…”

Quality by design with design of experiments approach for development of a stability‐indicating LC method for enzalutamide and its impurities in soft gel dosage formulation

“…However, there is no similar reference stability–indicating method for the corresponding dosage form testing. In a recent trend, the QbD (Ashok, Dongala, & Katakam, 2020; Katakam & Dongala, 2020a, 2020b; Katakam, Dongala, & Ettaboina, 2020; Panda, Bera, & Pradhan, 2019) approach was regulated for use in the pharmaceutical industry, with critical process parameters (CPPs) and critical quality attributes (CQAs) established for assessment of risk and design space for (method) operating conditions. A scientific way of explaining the design of experiments (DoE) approach involves performing a series of trails (usually 18) based on the fractional factorial design to evaluate the rapid and straightforward stability‐indicating UPLC method using ultraviolet detection prior to performing method validation studies.…”

Identification, isolation, and structure elucidation of novel forced degradation products of alectinib hydrochloride

“…Hence this analytical method has vast applicability in the pharmaceutical industry for quality control testing of alectinib and its related substances. The method would be extremely helpful to the pharmaceutical industries and academic scientists to identify any of the stated degradants in their drug substance [17–20].…”